The Directorate of Access to High-Cost Medications is exploring the possibility of expanding its treatment catalog. This process involves consultations with 11 specialized medical companies, which assess current medications and propose new molecules. At the same time, authorities are working to update the registry of doctors authorized to prescribe these medications, in order to improve access to care for patients.